384 related articles for article (PubMed ID: 23329397)
1. Platelet-rich plasma to improve the bio-functionality of biomaterials.
Anitua E; Tejero R; Alkhraisat MH; Orive G
BioDrugs; 2013 Apr; 27(2):97-111. PubMed ID: 23329397
[TBL] [Abstract][Full Text] [Related]
2. Blood-derived biomaterials and platelet growth factors in regenerative medicine.
Burnouf T; Goubran HA; Chen TM; Ou KL; El-Ekiaby M; Radosevic M
Blood Rev; 2013 Mar; 27(2):77-89. PubMed ID: 23434399
[TBL] [Abstract][Full Text] [Related]
3. Potential of endogenous regenerative technology for in situ regenerative medicine.
Anitua E; Sánchez M; Orive G
Adv Drug Deliv Rev; 2010 Jun; 62(7-8):741-52. PubMed ID: 20102730
[TBL] [Abstract][Full Text] [Related]
4. Perspectives and challenges in regenerative medicine using plasma rich in growth factors.
Anitua E; Alkhraisat MH; Orive G
J Control Release; 2012 Jan; 157(1):29-38. PubMed ID: 21763737
[TBL] [Abstract][Full Text] [Related]
5. Recent Achievements in the Development of Biomaterials Improved with Platelet Concentrates for Soft and Hard Tissue Engineering Applications.
Grzelak A; Hnydka A; Higuchi J; Michalak A; Tarczynska M; Gaweda K; Klimek K
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338805
[TBL] [Abstract][Full Text] [Related]
6. Toward delivery of multiple growth factors in tissue engineering.
Chen FM; Zhang M; Wu ZF
Biomaterials; 2010 Aug; 31(24):6279-308. PubMed ID: 20493521
[TBL] [Abstract][Full Text] [Related]
7. An overview of the therapeutic potential of regenerative medicine in cutaneous wound healing.
Pang C; Ibrahim A; Bulstrode NW; Ferretti P
Int Wound J; 2017 Jun; 14(3):450-459. PubMed ID: 28261962
[TBL] [Abstract][Full Text] [Related]
8. High-throughput proteomic characterization of plasma rich in growth factors (PRGF-Endoret)-derived fibrin clot interactome.
Anitua E; Prado R; Azkargorta M; Rodriguez-Suárez E; Iloro I; Casado-Vela J; Elortza F; Orive G
J Tissue Eng Regen Med; 2015 Nov; 9(11):E1-12. PubMed ID: 23505226
[TBL] [Abstract][Full Text] [Related]
9. Platelet-rich plasma (PRP) and Platelet-Rich Fibrin (PRF): surgical adjuvants, preparations for in situ regenerative medicine and tools for tissue engineering.
Bielecki T; Dohan Ehrenfest DM
Curr Pharm Biotechnol; 2012 Jun; 13(7):1121-30. PubMed ID: 21740380
[TBL] [Abstract][Full Text] [Related]
10. Platelet-rich plasma. A review.
Rodrigues SV; Acharya AB; Thakur SL
N Y State Dent J; 2012 Jan; 78(1):26-30. PubMed ID: 22474794
[TBL] [Abstract][Full Text] [Related]
11. A review on endogenous regenerative technology in periodontal regenerative medicine.
Chen FM; Zhang J; Zhang M; An Y; Chen F; Wu ZF
Biomaterials; 2010 Nov; 31(31):7892-927. PubMed ID: 20684986
[TBL] [Abstract][Full Text] [Related]
12. Enhancing intervertebral disc repair and regeneration through biology: platelet-rich plasma as an alternative strategy.
Wang SZ; Rui YF; Tan Q; Wang C
Arthritis Res Ther; 2013; 15(5):220. PubMed ID: 24165687
[TBL] [Abstract][Full Text] [Related]
13. Platelet-rich fibrin: a boon in regenerative endodontics.
Rebentish PD; Umashetty G; Kaur H; Doizode T; Kaslekar M; Chowdhury S
Minerva Stomatol; 2016 Dec; 65(6):385-392. PubMed ID: 27711028
[TBL] [Abstract][Full Text] [Related]
14. Platelet-rich preparations to improve healing. Part II: platelet activation and enrichment, leukocyte inclusion, and other selection criteria.
Davis VL; Abukabda AB; Radio NM; Witt-Enderby PA; Clafshenkel WP; Cairone JV; Rutkowski JL
J Oral Implantol; 2014 Aug; 40(4):511-21. PubMed ID: 25106017
[TBL] [Abstract][Full Text] [Related]
15. Blood Plasma Derivatives for Tissue Engineering and Regenerative Medicine Therapies.
Santos SCNDS; Sigurjonsson ÓE; Custódio CA; Mano JFCDL
Tissue Eng Part B Rev; 2018 Dec; 24(6):454-462. PubMed ID: 29737237
[TBL] [Abstract][Full Text] [Related]
16. Experimental tissue regeneration by DDS technology of bio-signaling molecules.
Kimura Y; Tabata Y
J Dermatol Sci; 2007 Sep; 47(3):189-99. PubMed ID: 17507205
[TBL] [Abstract][Full Text] [Related]
17. Microbicidal properties of Leukocyte- and Platelet-Rich Plasma/Fibrin (L-PRP/L-PRF): new perspectives.
Cieslik-Bielecka A; Dohan Ehrenfest DM; Lubkowska A; Bielecki T
J Biol Regul Homeost Agents; 2012; 26(2 Suppl 1):43S-52S. PubMed ID: 23648198
[TBL] [Abstract][Full Text] [Related]
18. Use of platelet growth factors in treating wounds and soft-tissue injuries.
Rozman P; Bolta Z
Acta Dermatovenerol Alp Pannonica Adriat; 2007 Dec; 16(4):156-65. PubMed ID: 18204746
[TBL] [Abstract][Full Text] [Related]
19. [Regenerative therapy for tendon and ligament disorders in horses. Terminology, production, biologic potential and in vitro effects].
Geburek F; Stadler P
Tierarztl Prax Ausg G Grosstiere Nutztiere; 2011; 39(6):373-83. PubMed ID: 22167082
[TBL] [Abstract][Full Text] [Related]
20. Autologous fibrin scaffolds: When platelet- and plasma-derived biomolecules meet fibrin.
Anitua E; Nurden P; Prado R; Nurden AT; Padilla S
Biomaterials; 2019 Feb; 192():440-460. PubMed ID: 30500725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
